No Data
No Data
The TOPIX 250 index in the Tokyo Stock Exchange's Growth Market experienced a historic drop, falling to levels not seen since the March 2020 COVID-19 shock.
The Tokyo Stock Exchange Growth Market Index was 749.04, down 58.55 points, with a volume of 0.3 billion 3.04 million shares and a turnover of 136.4 billion yen. The TSE Growth Market 250 Index was 576.29, down 46.96 points, with a volume of 0.2 billion 5.79 million shares and a turnover of 113.8 billion yen. Today's growth market saw both the TSE Growth Market Index and the TSE Growth Market 250 Index fall significantly. The number of rising stocks was 10, the number of falling stocks was 577, and the number of unchanged stocks was 1. The US stock market on the 1st day fell significantly, with the Dow down 494.82 dollars (-
Emerging Market Stock Digest: BS rises opposite, Shin Nippon Biomedical Laboratories falls significantly.
<7776> Cellseed 566 +24 continued to rise. Trading has become active due to the Tokyo Stock Exchange lifting the temporary credit trading measures from July 30th, and it continues to rise today. TSE had implemented regulations that commission margins for selling and buying new credit trading assets should be 50% or more (including cash of 20% or more). Japan Securities Finance has also lifted its additional collateral collection measures. <4883> Modaris 134 -9 significant decline. On August 2, Mr. Nuregi submitted his finances.
Cellseed continues to rise, with active trading continuing after the lifting of margin trading regulations.
Continuing rise. Trading has become active in response to the Tokyo Stock Exchange's lifting of temporary measures on margin trading from July 30, and it is still rising today. TSE had enforced regulations that require collateral rates of 50% or more (including cash of 20% or more) for new sales and purchases through margin trading. Japan Securities Finance has also lifted its additional collateral collection measures.
The TOPIX 250 index on the Tokyo Stock Exchange's Growth Market saw its largest decline of the year, as selling in the Prime Market spread.
The Tokyo Stock Exchange Growth Market Index is 807.59, down 29.21 points, with a volume of 0.3 billion 0.91 million shares and a turnover of 109 billion yen. The Tokyo Stock Exchange Growth Market 250 Index is 623.25, down 24.95 points, with a volume of 0.1 billion 60.82 million shares and a turnover of 83.4 billion yen. Today's growth market saw sharp declines in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. There were 58 advancing stocks, 513 declining stocks, and 15 unchanged. The U.S. stock market rose on July 31st. The Dow Jones Industrial Average rose 99.46 points (+0).
Emerging Markets Stock Digest: SBI Leasing sees significant rebound, Tobita Lab hits circuit breaker.
<4418> JDSC 729 +8 consecutive gains. After the close of trading on the 29th, it was announced that they had been entrusted with the "FY 2024 Survey of Administrative Procedures for Business Operators" by the Digital Agency and this was well received. In response to the challenge that procedures and information are not readily available from various ministries and agencies, the know-how of data infrastructure-related and consortium's concepts and insights, and the track record of DX business in each industry have been evaluated. The contract amount is 81,444,000 yen (including tax).
Hot stocks digest (morning session): Fujitsu, Sakura, SBI Leasing, etc.
Sakura <3778>: The stock price fell sharply by 400 yen to 3015 yen. The company reported its first quarter earnings the day before, and began offering GPU cloud services. Operating profit has increased significantly to 2.3 billion yen, 2.2 times more than the same period last year. However, the first half plan is 0.8 billion yen, which is 3.2 times higher than the same period last year, and progress is considered to be somewhat slow. The main reason for the cost increase is investment in personnel. Due to the issuance of new shares, stock issuance expenses, and the completion of guaranteed sales, net profit for the first quarter has significantly decreased.
No Data